METTL14 and metabolic disease: The phenotypes of Mettl14Δfat mice provide proof‐of‐concept evidence that Mettl14‐based epitranscriptomic inhibition of adipose β adrenergic signaling and lipolysis is a causal factor for obesity and its associated metabolic disorders.